BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korean diagnostics company NGeneBio is accelerating its expansion into the ASEAN precision diagnosis market.

▶ Securing breast and ovarian cancer precision diagnosis reference through clinical evaluation ▶ Expansion of opportunities to develops global advance...

January 19, 2023 | News

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

"We are pleased to collaborate with SK bioscience to offer our protein-based vaccine, Nuvaxovid, for use as a booster in adults regardless of previous vacc...

January 19, 2023 | News

Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes

Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping Lunit's presentations this year will highligh...

January 19, 2023 | News

Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), was awarded the Sustainable Markets Initiative's ...

January 11, 2023 | News

LegoChem Biosciences and Amgen Enter into a Multi-Target Research Collaboration

LCB Grants Amgen Rights to Research, Develop, and Commercialize Antibody-Drug Conjugates Combining Targets Selected by Amgen with LCB’s Proprieta...

December 26, 2022 | News

SK Biopharmaceuticals Unveils Vision for Digital Healthcare

SK Biopharmaceuticals plans to showcase wearable devices, including CES® 2023 Innovation Awards winners 'Zero GlassesTM,' 'Zero WiredTM'...

December 14, 2022 | News

SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France

SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that its European partner Angelini Pharma, an international pharmaceutical co...

December 09, 2022 | News

GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS

GenScript ProBio extended congratulations on this. Since December 2019, GenScript ProBio has joined the strategic collaboration with Selecxine for the...

December 07, 2022 | News

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Polytaxel, a novel pain-free anticancer drug, may not require break periods A new standard of care, more convenient than docetaxel, is suggest...

November 28, 2022 | News

South Korean diagnostics company NGeneBio is accelerating its expansion into the ASEAN precision diagnosis market.

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes

Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future

LegoChem Biosciences and Amgen Enter into a Multi-Target Research Collaboration

SK Biopharmaceuticals Unveils Vision for Digital Healthcare

SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France

GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

Lunit Partners with CARPL.ai to Accelerate AI-Powered Medical Imaging Across Major Overseas Channels

제조 실행 소프트웨어(MES) 도입에 대한 6가지 일반적인 오해 해소

Lunit Becomes the First Medical Software Company in Asia-Pacific to Become MDR CE and UKCA Certified

Stay Connected